logoTry Persana

FidoCure® - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about FidoCure® including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

FidoCure® company logo

AI-enabled precision medicine platform for canine cancer: Fighting cancer on both ends of the leash.

FidoCure is the first and only service to offer cancer care with a dual-focus approach that benefits both dogs and humans. Leveraging the genetic similarities between human and canine cancers, FidoCure offers targeted therapies that allow for more effective treatments extending dog lives by up to 3x.

HeadquartersPalo Alto, California, United States
Team size11-50
Founded2018

What is FidoCure®? - Company Overview & Details

FidoCure® is FidoCure is the first and only service to offer cancer care with a dual-focus approach that benefits both dogs and humans. Leveraging the genetic similarities between human and canine cancers, FidoCure offers targeted therapies that allow for more effective treatments extending dog lives by up to 3x. Founded in 2018, the company is headquartered in Palo Alto, California, United States.

Who Founded FidoCure®?

FidoCure® was founded by Christina Lopes.

Who are the Key Executives at FidoCure®? - Leadership Team

FidoCure® is led by experienced executives in key positions:

Chief Executive Officer (CEO) of FidoCure®

Christina LopesCEO

About Christina Lopes - CEO of FidoCure®

Christina Lopes serves as the Chief Executive Officer of FidoCure®, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

FidoCure® Company Details & Key Information

Where is FidoCure® located?

FidoCure® is headquartered in Palo Alto, California, United States.

How many employees does FidoCure® have?

FidoCure® has 11-50 employees.

When was FidoCure® founded?

FidoCure® was founded in 2018.

FidoCure® Official Website

How much funding has FidoCure® raised?

FidoCure® has raised undisclosed amount.

N/A
Total Funding Raised
0
Funding Rounds
N/A
Latest Round

Who are the key investors in FidoCure®?

FidoCure® is backed by 3 key investors including Polaris Ventures, A16Z, YCombinator. These investors focus on sectors.

FidoCure® Investor Overview

3
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of FidoCure® Investors

Polaris Ventures

A16Z

YCombinator

What sectors do FidoCure® investors focus on?

The investors backing FidoCure® primarily focus on sectors.

Featured Investor: Polaris Ventures

Polaris Ventures

Notable Investments:

What are FidoCure®'s future plans?

Future Plans Information Not Available

Detailed information about FidoCure®'s future plans and strategic initiatives is not currently available in our database.

What are the latest news about FidoCure®?

FidoCure® has 2 recent news updates covering key business developments and market activities.

FidoCure® News Overview

2
Recent Articles
Active
Media Coverage
2021-12-06
Latest Update

What is FidoCure® in the news for?

FidoCure® is currently featured in news for FidoCure to Present at the Veterinary Cancer Society Conference and other significant business developments.

Recent News Articles About FidoCure®

Article 1
2021-12-06

FidoCure to Present at the Veterinary Cancer Society Conference

FidoCure is looking forward to the Veterinary Cancer Society conference, showcasing data-rich presentations on canine cancer.

Read News
Article 2
2025-06-03

New Study Identifies Genetic Mutations in Canine Cancer

A study published in Nature reveals genetic mutations influencing treatment responses in splenic hemangiosarcoma, offering new hope for canine cancer patients.

Read News

FidoCure® FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about FidoCure® including information about founders, CEO, funding history, investors, headquarters location, and company details. 12 frequently asked questions covering key information about the company.

FidoCure® Questions & Answers - Company Information

Q1

What is FidoCure®?

FidoCure is the first and only service to offer cancer care with a dual-focus approach that benefits both dogs and humans. Leveraging the genetic similarities between human and canine cancers, FidoCure offers targeted therapies that allow for more effective treatments extending dog lives by up to 3x.

Q2

Who founded FidoCure®?

FidoCure® was founded by Christina Lopes.

Q3

Who is the CEO of FidoCure®?

The CEO of FidoCure® is Christina Lopes. You can find more information about them on their LinkedIn profile.

Q4

Who are the investors in FidoCure®?

FidoCure®'s key investors include Polaris Ventures, A16Z, YCombinator.

Q5

Where is FidoCure® headquartered?

FidoCure® is headquartered in Palo Alto, California, United States.

Q6

When was FidoCure® founded?

FidoCure® was founded in 2018.

Q7

How many employees does FidoCure® have?

FidoCure® has 11-50 employees.

Q8

What is FidoCure®'s official website?

You can visit FidoCure®'s official website at http://www.fidocure.com.

Q9

Who is founder?

Christina Lopes

Q10

What does the company do?

FidoCure provides personalized cancer treatments for dogs using AI and genomic sequencing to enhance their health and survival.

Q11

Who are the investors?

Polaris Ventures A16Z YCombinator

Q12

Latest news?

FidoCure is looking forward to the Veterinary Cancer Society conference, showcasing data-rich presentations on canine cancer. A study published in Nature reveals genetic mutations influencing treatment responses in splenic hemangiosarcoma, offering new hope for canine cancer patients.

More Information About FidoCure®

For additional details about FidoCure®, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.